HAEMONETICS CORPORATION

Company

HAEMONETICS CORP

Filed

February 15, 2017

Accession Number

0000891804-17-000140

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →